Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors.
暂无分享,去创建一个
Wounjhang Park | Andrew P Goodwin | Jennifer N Cha | J. Cha | W. Park | Andrew P. Goodwin | Michael Brasino | Shambojit Roy | Annette H Erbse | Liangcan He | Chenchen Mao | Liangcan He | M. Brasino | A. Erbse | Chenchen Mao | Shambojit Roy
[1] M. Tabrizi,et al. Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease , 2010, The AAPS Journal.
[2] R. Kontermann,et al. Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL). , 2009, Bioconjugate chemistry.
[3] S. Ståhl,et al. Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry , 2009, Journal of Nuclear Medicine.
[4] Li Yan,et al. How can we improve antibody-based cancer therapy? , 2009, mAbs.
[5] Zhen Cheng,et al. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. , 2010, Bioconjugate chemistry.
[6] Fredrik Y Frejd,et al. Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications , 2010, FEBS letters.
[7] H. Brismar,et al. Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor. , 2007, Protein engineering, design & selection : PEDS.
[8] J. Carlsson,et al. Effects of an EGFR-binding affibody molecule on intracellular signaling pathways. , 2010, International journal of oncology.
[9] I. Hamachi,et al. Analysis of Cell-Surface Receptor Dynamics through Covalent Labeling by Catalyst-Tethered Antibody. , 2015, Journal of the American Chemical Society.
[10] Vladimir Tolmachev,et al. Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Zhen Cheng,et al. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors. , 2010, Journal of biomedical optics.
[12] R. Weissleder. A clearer vision for in vivo imaging , 2001, Nature Biotechnology.
[13] A. Speghini,et al. Colloidal Tm3+/Yb3+‐Doped LiYF4 Nanocrystals: Multiple Luminescence Spanning the UV to NIR Regions via Low‐Energy Excitation , 2009 .
[14] Hjalmar Brismar,et al. Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. , 2007, Nuclear medicine and biology.
[15] Shuo Diao,et al. A small-molecule dye for NIR-II imaging. , 2016, Nature materials.
[16] Fredrik Y Frejd,et al. Quantification of internalization of EGFR-binding Affibody molecules: Methodological aspects. , 2010, International journal of oncology.
[17] L. Abrahmsén,et al. Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition , 2012, The Journal of Nuclear Medicine.
[18] J. Sleeman,et al. Tumor‐initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long‐term culturing as adherent monolayers , 2013, International journal of cancer.
[19] Andrew B. Martin,et al. Addition of a photocrosslinking amino acid to the genetic code of Escherichia coli , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] G. Adams,et al. Affinity and avidity in antibody-based tumor targeting. , 2009, Cancer biotherapy & radiopharmaceuticals.
[21] P. Nygren,et al. Alternative binding proteins: Affibody binding proteins developed from a small three‐helix bundle scaffold , 2008, The FEBS journal.
[22] W. Jiskoot,et al. Taylor Dispersion Analysis Compared to Dynamic Light Scattering for the Size Analysis of Therapeutic Peptides and Proteins and Their Aggregates , 2011, Pharmaceutical Research.
[23] T. Huber,et al. Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers. , 2011, Biochemistry.
[24] Jesse V Jokerst,et al. Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor. , 2011, Small.
[25] J. Cha,et al. DNA-Assembled Core-Satellite Upconverting-Metal-Organic Framework Nanoparticle Superstructures for Efficient Photodynamic Therapy. , 2017, Small.
[26] E. Johansson,et al. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. , 2008, Journal of molecular biology.
[27] A. Tsourkas,et al. Optimization of Photoactive Protein Z for Fast and Efficient Site-Specific Conjugation of Native IgG , 2014, Bioconjugate chemistry.